MedPath

Psychosocial Distress and Quality of Life in CDKN2A Pathogenic Variant Carriers and their first-degree relatives

Recruiting
Conditions
CDKN2A P16-Leiden
10027664
10002861
10016214
Registration Number
NL-OMON53436
Lead Sponsor
eids Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
500
Inclusion Criteria

- 18 years or older
- Written informed consent
- Proven CDKN2A PV carrier (confirmed by positive genetic test result)
OR
- CDKN2A risk carrier (50% chance of carrying the PV; genetic status not [yet]
confirmed by genetic testing)
- Participation in the LUMC skin and/or pancreatic surveillance program

Exclusion Criteria

Individuals that are not able to read or understand Dutch will be excluded from
participation in this study.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>First, the questionnaire aims to explore the psychological distress and quality<br /><br>of life by validated questionnaires including CWS, HADS, and SF-12. Second, the<br /><br>psychosocial impact on lifestyle, genetic testing, skin and pancreatic<br /><br>surveillance, and family planning is examined by both self-developed and<br /><br>validated questionnaires (PAHC, DCS).<br /><br><br /><br>Our primary objectives are:<br /><br>- To investigate the quality of life and psychological distress in CDKN2A PV<br /><br>carriers and their first-degree relatives;<br /><br>- To assess the psychosocial impact of the CDKN2A PV on daily life, with<br /><br>regards to the following four themes: 1) lifestyle, 2) genetic testing, 3) skin<br /><br>and pancreatic screening, and 4) family planning.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>- To investigate whether psychosocial outcomes differ between CDKN2A PV<br /><br>carriers and first-degree relatives;<br /><br>- To identify individuals who may benefit from additional psychological support.<br /><br>- To develop a website and decision aid to help PV carriers and first-degree<br /><br>relatives with complex choices associated with the PV, such as engagement in<br /><br>genetic testing and cancer screening, lifestyle, and family planning. </p><br>
© Copyright 2025. All Rights Reserved by MedPath